Citations

Showing 10 of 108083 citations.

DNA Sequencing to Detect Residual Disease in Adults With Acute Myeloid Leukemia Prior to Hematopoietic Cell Transplant
Gui, Gege , Page, Kristin , Ravindra, Niveditha , Wong, Zoë C. , Andrew, Georgia , Mukherjee, Devdeep , Howard, Alan , Chen, Karen , Auletta, Jeffery J. , Lima, Marcos J.G. De, Litzow, Mark R. , Saber, Wael , Weisdorf, Daniel J. , Weisdorf, Dan , Auletta, Jeffery J , Dillon, Laura Williams , Mukherjee, Devdeep, Zeger, Scott L. , Chaer, Firas El , Spellman, Stephen R. , Howard, Alan, Devine, Steven M. , Jiménez, Antonio , Kebriaei, Partow , Hourigan, Christopher S.

Mayo Clinic

JAMA | March 7, 2023 | Volume: 329 | Issue: 9 | Pages: 745

10.1001/jama.2023.1363 | PMID 36881031 Get It

Importance Preventing relapse for adults with acute myeloid leukemia (AML) in first remission is the most common indication for allogeneic hematopoietic cell transplant. The presence of AML measurable residual disease (MRD) has been associated with higher relapse rates, but testing is not standardized. Objective To determine whether DNA sequencing to identify residual variants in the blood of adults with AML in first remission before allogeneic hematopoietic cell transplant identifies patients at increased risk of relapse and poorer overall survival compared with those without these DNA variants. Design, Setting, and Participants In this retrospective observational study, DNA sequencing was performed on pretransplant blood from patients aged 18 years or older who had undergone their first allogeneic hematopoietic cell transplant during first remission for AML associated with variants in FLT3, NPM1, IDH1, IDH2, or KIT at 1 of 111 treatment sites from 2013 through 2019. Clinical data were collected, through May 2022, by the Center for International Blood and Marrow Transplant Research. Exposure Centralized DNA sequencing of banked pretransplant remission blood samples. Main Outcomes and Measures The primary outcomes were overall survival and relapse. Day of transplant was considered day 0. Hazard ratios were reported using Cox proportional hazards regression models. Results Of 1075 patients tested, 822 had FLT3 internal tandem duplication ( FLT3- ITD) and/or NPM1 mutated AML (median age, 57.1 years, 54% female). Among 371 patients in the discovery cohort, the persistence of NPM1 and/or FLT3 -ITD variants in the blood of 64 patients (17.3%) in remission before undergoing transplant was associated with worse outcomes after transplant (2013-2017). Similarly, of the 451 patients in the validation cohort who had undergone transplant in 2018-2019, 78 patients (17.3%) with residual NPM1 and/or FLT3 -ITD variants had higher rates of relapse at 3 years (68% vs 21%; difference, 47% [95% CI, 26% to 69%]; HR, 4.32 [95% CI, 2.98 to 6.26]; P < .001) and decreased survival at 3 years (39% vs 63%; difference, −24% [2-sided 95% CI, −39% to −9%]; HR, 2.43 [95% CI, 1.71 to 3.45]; P < .001). Conclusions and Relevance Among patients with acute myeloid leukemia in first remission prior to allogeneic hematopoietic cell transplant, the persistence of FLT3 internal tandem duplication or NPM1 variants in the blood at an allele fraction of 0.01% or higher was associated with increased relapse and worse survival compared with those without these variants. Further study is needed to determine whether routine DNA-sequencing testing for residual variants can improve outcomes for patients with acute myeloid leukemia.
Importance of Surface-modified Nanocarriers in the Management of Cervical Cancer
Rachamalla, Hari Krishnareddy , Rachamala, Hari Krishnareddy , Madamsetty, Vijay Sagar

Mayo Clinic

Therapeutic Nanocarriers in Cancer Treatment: Challenges and Future Perspective | March 7, 2023 | Volume: No volume available | Issue: No issue available | Pages: 211-227

10.2174/9789815080506123010010 Get It

Cervical cancer (CC) is women's fourth most occurring malignancy, with a high death rate. Every CC patient is related to infection with high-risk human papillomaviruses (HPV), predominantly transmitted through sexual contact. Early diagnosis of CC helps treat surgical removal of tumours, leading to an increased patient life span. However, existing detection methods of CC, like Pap smear test, have very low sensitivity. Even though preventive vaccines for CC are doing well, they cannot protect against all HPV cancers and potential side effects. Additionally, chemotherapy for CC has had a detrimental impact because of the lack of selective tumour cell toxicity, resulting in higher adverse effects. Despite significant progress in oncology research, efficient CCs treatment is still challenging, and target-selective drug delivery formulations with a systematic release mechanism potentially avoid and reduce biotoxicity. Recent developments in nanomedicine and nanotechnology are creating more interest in developing new treatment strategies for CC treatment. Materials used in nanomedicine development are made up of synthetic or natural. These nanoparticles pointedly impacted therapeutic applications with enhanced specificity and unique personalized assets. Surface-engineered nanoparticles offer a massive possibility for compatibility with biological agents, including nucleic acids, proteins, etc. Surface fictionalization nanoparticles with targeting ligands further help in selective targeting. The present study summarizes recent advancements in surface-modified nanoparticlebased CC treatment methodologies.<br>
Targeted Nanocarriers-based Approach For Prostate Cancer Therapy
Garg, Ashish , Madamsetty, Vijay Sagar , Ashique, Sumel , Gauttam, Vinod Kumar , Mishra, Neeraj

Mayo Clinic

Therapeutic Nanocarriers in Cancer Treatment: Challenges and Future Perspective | March 7, 2023 | Volume: No volume available | Issue: No issue available | Pages: 133-162

10.2174/9789815080506123010008 Get It

Prostate cancer is the most common malignancy in men, with elevated morbidity and mortality. The current management, along with dope, leads to chemo defiance. On molecular imaging, many researchers have assisted with staging, restaging, early diagnosis, and, particularly, prostate cancer healing. At the site of cancer, treatment of prostate cancer, including chemo, has encountered many difficulties, such as quick clearance of dope or defiance of drug and short accumulation. Nanotechnology applications and their use in biomedicine to deliver various therapeutic carriers fitted to relieve deputy chemotherapy for cancer treatment. The tumor-targeted dope delivery-related carriers are outlined for prostate cancer healing. Among them, the developing nanotechnology has introduced several innovative new testing technologies, and medications for prostate cancer nanotechnology can significantly increase the management operation of prostate cancer by using specific physical and chemical properties, targeting techniques, or anchoring with imaging / pharmacological substances to provide an innovative theranostics device. This chapter focused on the ultra-modern outgrowth in the observation of nanomaterial and the identity of prostate cancer, including the representation of modes used to point biomolecules operationalization and the various prostate cancers along with nanoparticles, multifunctional nanoplatforms, and nano-related methods of dope delivery in the administration.&nbsp;<br>
Response to comment on ‘Environmental impact of single‐use and reusable flexible cystoscopes’
Kemble, Jayson , Koo, Kevin , Kemble, Jayson P

Mayo Clinic

BJU International | March 7, 2023 | Volume: 131 | Issue: 5 | Pages: 635-635

10.1111/bju.16004 | PMID 36880941 Get It

Financial, policy, and ethical barriers to the expansion of living donor liver transplant: Meeting report from a living donor liver transplant consensus conference
Pillai, Anjana , Verna, Elizabeth C. , Parikh, Neehar D. , Cooper, Matthew , Thiessen, Carrie , Mathur, Amit K. , Perito, Emily R. , Liapakis, AnnMarie , Group, AST LDLT Consensus Conference Working, Mathur, Amit , Jesse, Michelle , Cooper, Matthew , Parikh, Neehar D , Heimbach, Julie K. , Gordon, Elisa J. , Sapisochín, Gonzalo , Selzner, Nazia , Kumar, Vineeta , Group, AST LDLT Consensus Conference Working

Mayo Clinic

Clinical Transplantation | March 7, 2023 | Volume: 37 | Issue: 7 | Pages: No page available

10.1111/ctr.14955 | PMID 36880375 Get It

AbstractIntroductionIn October 2021, the American Society of Transplantation (AST) hosted a virtual consensus conference aimed at identifying and addressing barriers to the broader, safe expansion of living donor liver transplantation (LDLT) throughout the United States (US).MethodsA multidisciplinary group of LDLT experts convened to address issues related to financial implications on the donor, transplant center crisis management, regulatory and oversight policies, and ethical considerations by assessing the relative significance of issues in preventing LDLT growth, with proposed strategies to overcome barriers.ResultsLiving liver donors endure multiple obstacles including financial instability, loss of job security, and potential morbidity. These concerns, along with other center, state, and federal specific policies can be perceived as significant barriers to expanding LDLT. Donor safety is of paramount importance to the transplant community; however, regulatory and oversight policies aimed at ensuring donor safety can be viewed as ambiguous and complicated leading to time‐consuming evaluations that may deter donor motivation and program expansion.ConclusionTransplant programs need to establish appropriate crisis management plans to mitigate potential negative donor outcomes and ensure program viability and stability. Finally, ethical aspects, including informed consent for high‐risk recipients and use of non‐directed donors, can be perceived as additional barriers to expanding LDLT.
Spectrum of renal pathological findings in patients with chronic myelomonocytic leukemia and kidney injury
Gipe, Nate, Leung, Nelson , Mangaonkar, Abhishek A. , Al‐Kali, Aref , Gangat, Naseema , McCullough, Kristen , Tefferi, Ayalew , Alexander, Mariam P., Patnaik, Mrinal M. , Mangaonkar, Abhishek A. , Tefferi, Ayalew , Alexander, Mariam Priya, Patnaik, Mrinal , Leung, Nelson , McCullough, Kristen B , Lasho, Terra L. , Alkhateeb, Hassan B. , Hogan, William J.

Mayo Clinic

American Journal of Hematology | March 7, 2023 | Volume: 98 | Issue: 6 | Pages: No page available

10.1002/ajh.26902 | PMID 36880366 Get It

Comparison of nimodipine formulations and administration techniques via enteral feeding tubes in patients with aneurysmal subarachnoid hemorrhage: A multicenter retrospective cohort study
Mahmoud, Sherif Hanafy , Hefny, Fatma , Panos, Nicholas , Delucilla, Laura, Ngan, Zinquon, Perreault, Marc M. , Hamilton, Leslie A. , Rowe, A. Shaun , Buschur, Pamela , Owusu‐Guha, Jocelyn , Almohaish, Sulaiman , Sandler, Melissa , Armahizer, Michael , Barthol, Colleen , Hintze, Trager D , Cantin, Anna, Traeger, Jessica, Blunck, Joseph R. , Shewmaker, Justin , Burgess, Sarah , Kaupp, Kristin , Brown, Caitlin S. , Clark, Sarah L. , Wieruszewski, Erin D. , Tesoro, Eljim P. , Ammar, Abdalla , Binning, Mandy J., Naydin, Stanislav, Fox, Neal S., Peters, David M. , Mahmoud, Leana , Keegan, Shaun, Hefny, Fatma R , Cook, Aaron M , Blunck, Joseph R , Brown, Caitlin S , Ammar, Mahmoud A , Peters, David M , Brophy, Gretchen M , Barra, Megan E. , Cook, Aaron M. , Brophy, Gretchen M.

Mayo Clinic

Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy | March 7, 2023 | Volume: 43 | Issue: 4 | Pages: 279-290

10.1002/phar.2791 | PMID 36880540 Get It

AbstractBackgroundNimodipine improves outcomes following aneurysmal subarachnoid hemorrhage (aSAH) and current guidelines suggest that patients with aSAH receive nimodipine for 21 days. Patients with no difficulty swallowing will swallow the whole capsules or tablets; otherwise, nimodipine liquid must be drawn from capsules, tablets need to be crushed, or the commercially available liquid product be used to facilitate administration through an enteral feeding tube (FT). It is not clear whether these techniques are equivalent. The goal of the study was to determine if different nimodipine formulations and administration techniques were associated with the safety and effectiveness of nimodipine in aSAH.MethodsThis was a retrospective multicenter observational cohort study conducted in 21 hospitals across North America. Patients admitted with aSAH and received nimodipine by FT for ≥3 days were included. Patient demographics, disease severity, nimodipine administration, and study outcomes were collected. Safety end points included the prevalence of diarrhea and nimodipine dose reduction or discontinuation secondary to blood pressure reduction. Predictors of the study outcomes were analyzed using regression modeling.ResultsA total of 727 patients were included. Administration of nimodipine liquid product was independently associated with higher prevalence of diarrhea compared to other administration techniques/formulations (Odds ratio [OR] 2.28, 95% confidence interval [CI] 1.41–3.67, p‐value = 0.001, OR 2.76, 95% CI 1.37–5.55, p‐value = 0.005, for old and new commercially available formulations, respectively). Bedside withdrawal of liquid from nimodipine capsules prior to administration was significantly associated with higher prevalence of nimodipine dose reduction or discontinuation secondary to hypotension (OR 2.82, 95% CI 1.57–5.06, p‐value = 0.001). Tablet crushing and bedside withdrawal of liquid from capsules prior to administration were associated with increased odds of delayed cerebral ischemia (OR 6.66, 95% CI 3.48–12.74, p‐value <0.0001 and OR 3.92, 95% CI 2.05–7.52, p‐value <0.0001, respectively).ConclusionsOur findings suggest that enteral nimodipine formulations and administration techniques might not be equivalent. This could be attributed to excipient differences, inconsistency and inaccuracy in medication administration, and altered nimodipine bioavailability. Further studies are needed.
Iron deficiency in pulmonary vascular disease: pathophysiological and clinical implications
Martens, Pieter , Yu, Shilin , Larive, Brett , Erzurum, Serpil C. , Farha, Samar , Finet, J. Emanuel , Grünig, Gabriele , Hill, Nicholas S. , Jacob, Miriam , Kwon, Deborah , Park, Margaret , Wilcox, Jennifer , Tang, W.H. Wilson , Group, the PVDOMICS Study, Horn, Evelyn M , Tang, W H Wilson , Wilcox, Jennifer D , Borlaug, Barry A. , Hemnes, Anna R. , Horn, Evelyn M. , Rischard, Franz , Rosenzweig, Erika B. , Group, the PVDOMICS Study

Mayo Clinic

European Heart Journal | March 7, 2023 | Volume: 44 | Issue: 22 | Pages: 1979-1991

10.1093/eurheartj/ehad149 | PMID 36879444 Get It

Abstract Aims Iron deficiency is common in pulmonary hypertension, but its clinical significance and optimal definition remain unclear. Methods and results Phenotypic data for 1028 patients enrolled in the Redefining Pulmonary Hypertension through Pulmonary Vascular Disease Phenomics study were analyzed. Iron deficiency was defined using the conventional heart failure definition and also based upon optimal cut-points associated with impaired peak oxygen consumption (peakVO2), 6-min walk test distance, and 36-Item Short Form Survey (SF-36) scores. The relationships between iron deficiency and cardiac and pulmonary vascular function and structure and outcomes were assessed. The heart failure definition of iron deficiency endorsed by pulmonary hypertension guidelines did not identify patients with reduced peakVO2, 6-min walk test, and SF-36 (P &gt; 0.208 for all), but defining iron deficiency as transferrin saturation (TSAT) &lt;21% did. Compared to those with TSAT ≥21%, patients with TSAT &lt;21% demonstrated lower peakVO2 [absolute difference: −1.89 (−2.73 to −1.04) mL/kg/min], 6-min walk test distance [absolute difference: −34 (−51 to −17) m], and SF-36 physical component score [absolute difference: −2.5 (−1.3 to −3.8)] after adjusting for age, sex, and hemoglobin (all P &lt; 0.001). Patients with a TSAT &lt;21% had more right ventricular remodeling on cardiac magnetic resonance but similar pulmonary vascular resistance on catheterization. Transferrin saturation &lt;21% was also associated with increased mortality risk (hazard ratio 1.63, 95% confidence interval 1.13–2.34; P = 0.009) after adjusting for sex, age, hemoglobin, and N-terminal pro-B-type natriuretic peptide. Conclusion The definition of iron deficiency in the 2022 European Society of Cardiology (ESC)/European Respiratory Society (ERS) pulmonary hypertension guidelines does not identify patients with lower exercise capacity or functional status, while a definition of TSAT &lt;21% identifies patients with lower exercise capacity, worse functional status, right heart remodeling, and adverse clinical outcomes.
Are the New Biologics Effective in the Management of Postoperative Crohn’s Disease?
Mourad, Fadi H. , Maalouf, Rami George, Aoun, Roni , Hashash, Jana G. , Hashash, Jana G , Kotze, Paulo Gustavo

Mayo Clinic

Inflammatory Bowel Diseases | March 7, 2023 | Volume: 30 | Issue: 3 | Pages: 459-469

10.1093/ibd/izad033 | PMID 36879404 Get It

Abstract Background Despite the growing therapeutic armamentarium, at least half of the patients with Crohn’s disease will require surgery during their lifetime. Current evidence for the prevention and treatment of postoperative Crohn’s disease supports the use of anti-tumor necrosis factor agents with limited data about the use of the newer biologics, vedolizumab and ustekinumab. Methods We performed a systematic review of available data to determine the efficacy of the newer biologics in the management of postoperative Crohn’s disease. We included noncomparative and comparative studies. The main outcomes of interest were clinical and endoscopic postoperative recurrence rates. Results The search strategy identified 1231 citations, with 32 eligible for review. Several studies showed that the postoperative Crohn’s disease recurrence rates with the use of the newer biologics were comparable to previously published results with the use of anti-tumor necrosis factor agents, while other studies failed to show their efficacy. It is important to note that the studies were heterogeneous and included a relatively small sample size, making it difficult to draw a definite conclusion about the efficacy of the newer biologics in the management of postoperative Crohn’s disease. Conclusion The newer biologics do play a role in the management of postoperative Crohn’s disease. After our review, we proposed an updated algorithm on the role of newer biologics in the approach to patients with postoperative Crohn’s disease. Yet, until we have better-designed studies, their definite positioning remains to be determined.
Leadership and Professionalism Curriculum in the Gross Anatomy Course
Pawlina, Wojciech, Hromanik, Michael J, Milanese, Tia R, Dierkhising, Ross , Viggiano, Thomas R., Carmichael, Stephen W.

Mayo Clinic

Annals of the Academy of Medicine, Singapore | March 7, 2023 | Volume: 35 | Issue: 9 | Pages: 609-614

10.47102/annals-acadmedsg.v35n9p609 Get It

Introduction: Today’s physicians must demonstrate both professionalism and leadership skills in order to succeed in largely team-based healthcare environments. The purpose of this study was to determine if professionalism attributes, leadership style, and leadership style adaptability are associated with academic performance among first-year students early in their medical curriculum. Materials and Methods: Students were divided into 4-member dissection groups for the duration of the Gross and Developmental Anatomy course. Leadership responsibility was randomly assigned to a team member on a rotating basis every 5 weeks. After each 5-week block, student performance was measured by written and practical examinations, and each student assessed their leader’s or their own professionalism attributes and leadership style using validated survey instruments. Results: Most students demonstrated either a “selling” only (57%) or “participating” only (30%) leadership style with low to moderate leadership adaptability. “Participating” and “delegating” leadership styles have the highest average group written exam scores (89.4%, P <0.008). “Telling” only or “selling” only leaders have the lowest average group exam scores (83.5%, P <0.001). “Selling” and “participating” leaders have significantly lower average group practical exam scores than other styles (81.5%, P <0.007). Positive associations were observed between the written and practical examination scores and the leader’s integrity (P = 0.003, P = 0.002) and responsibility (P <0.001 , P = 0.037). Conclusions: This study demonstrates that various situational leadership styles and aspects of professionalism are associated with written and practical examination scores in the Gross and Developmental Anatomy course. Furthermore, it demonstrates that first-year medical students are in need of leadership skill development. Key words: Basic science, Gross anatomy, Leadership style, Medical curriculum, Teamwork, Team-based learning